Skip to main content
SpringerLink
Log in

Turning off the inflammatory, but not the metabolic, flames

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This article has been updated

Metabolically driven, chronic, low-grade inflammation has a crucial role in the pathogenesis of obesity and type 2 diabetes, and multiple stress-signaling cascades link insulin resistance and the immune response. An approved immunomodulatory drug is now shown to inhibit the kinases IKKε and TBK1, suppress inflammation and improve metabolic homeostasis in mouse models of obesity (pages 313–321).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Signaling pathways involved in classical inflammation and metaflammation.

Marina Corral

Change history

  • 22 March 2013

     In the version of this article initially published, TBK1 was incorrectly referred to in a number of instances as TKB1. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Gregor, M.F. & Hotamisligil, G.S. Annu. Rev. Immunol. 29, 415–445 (2011).

    Article  CAS  Google Scholar 

  2. Olefsky, J.M. & Glass, C.K. Annu. Rev. Physiol. 72, 219–246 (2010).

    Article  CAS  Google Scholar 

  3. Odegaard, J.I. & Chawla, A. Science 339, 172–177 (2013).

    Article  CAS  Google Scholar 

  4. Johnson, A.R., Milner, J.J. & Makowski, L. Immunol. Rev. 249, 218–238 (2012).

    Article  CAS  Google Scholar 

  5. Hirosumi, J. et al. Nature 420, 333–336 (2002).

    Article  CAS  Google Scholar 

  6. Yuan, M. et al. Science 293, 1673–1677 (2001).

    Article  CAS  Google Scholar 

  7. Arkan, M.C. et al. Nat. Med. 11, 191–198 (2005).

    Article  CAS  Google Scholar 

  8. Nakamura, T. et al. Cell 140, 338–348 (2010).

    Article  CAS  Google Scholar 

  9. Carvalho-Filho, M.A. et al. Endocrinology 153, 5261–5274 (2012).

    Article  CAS  Google Scholar 

  10. Reilly, S.M. et al. Nat. Med. 19, 313–321 (2013).

    Article  CAS  Google Scholar 

  11. Baker, R.G., Hayden, M.S. & Ghosh, S.N.F. Cell Metab. 13, 11–22 (2011).

    Article  CAS  Google Scholar 

  12. Chiang, S.-H. et al. Cell 138, 961–975 (2009).

    Article  CAS  Google Scholar 

  13. Scheja, L., Heese, B. & Seedorf, K. Biochem. Biophys. Res. Commun. 407, 288–294 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ediz S. Calay and Gökhan S. Hotamisligil are in the Department of Genetics and Complex Diseases and the Broad Institute of Massachusetts Institute of Technology and Harvard University, Harvard School of Public Health, Boston, Massachusetts, USA.,

    Ediz S. Calay & Gökhan S. Hotamisligil

Authors
  1. Ediz S. Calay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gökhan S. Hotamisligil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gökhan S. Hotamisligil.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calay, E., Hotamisligil, G. Turning off the inflammatory, but not the metabolic, flames. Nat Med 19, 265–267 (2013). https://doi.org/10.1038/nm.3114

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3114

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation